Back to top

We are a bioprocess engineering company engaged in design, development and manufacturing of innovative Single-use bioreactor platforms and bioprocess technologies. Driven by our visionary principle “Limitless Bioprocessing”, we are inspired to deliver comprehensive solutions to improve the quality, scalability and efficiency of biologics manufacturing processes. Our sterling technologies, steadfast technical support and expert guidance enable researchers and manufacturers to optimize the full potential of bioprocessing across a wide range of bio industries.

  • Vision

    By 2030, we shall redefine the way biomanufacturing happens with our transformative single-use technologies, delivering global access to next-generation biologics & cell therapies.

  • Mission

    To engineer advanced bioprocessing platforms that accelerate innovation, scale with precision, and empower the future of biologics manufacturing.

  • Core Values

    Guided by our principle of “Limitless Bioprocessing”, we strive to:

    • Innovate
    • Empower people & industry
    • Build partnerships & Collaborations
    • Integrity & Respect

    Together, we are redefining the boundaries of bioprocessing for a healthier and more sustainable world.

Our Solutions

Bring immense value to customers in several ways

01

Scalability

Seamlessly scale from lab to GMP production with bioreactors designed for consistent performance across volumes—from 0.5L to 200L. No revalidation hassles, just smooth process transfer.

02

High Throughput Efficiency

Accelerate your workflows with systems built for rapid batch processing and parallel scalability. Boost output without compromising on control or quality.

03

Affordability

Streamline operations with single-use systems that cut costs on cleaning, downtime, and compliance—without sacrificing performance or innovation.

04

Single use yet Customizable

Enjoy plug-and-play convenience with the freedom to configure. Our modular, Customization for single-use bioreactors adapt to your unique process needs—flexibility without the footprint.

Our Offices

Closer to You, Committed to You: Explore Our locations near you

India (Corporate Office)

Our headquarters located in the northern suburbs of Ahmedabad is a home to dedicated team of R&D, application scientists and commercial team which focuses on innovating and optimizing our bioreactor technology based on commercial requirements. Our team constantly thrives to understand your specific bioprocessing challenges, queries related to bioprocess needs, starting from process optimization to troubleshooting and recommend the perfect solution to maximize your research and manufacturing efficiency

 

“Welcome to an integrated hub of scientific excellence!”

India (Manufacturing Plant)

Located in the vibrant western suburbs of Ahmedabad, our state-of-the-art manufacturing plant serves as the foundation for our innovative journey. From design to manufacturing of high-end single use bioreactors, we uphold the highest quality benchmarks. While ensuring strict adherence to sterile manufacturing practices, complying with ISO 9001:2015, ISO 13485, and GMP equivalent regulations, we try to achieve customer satisfaction and operational excellence.

USA

OmniBRx successfully established its global footprint. Incorporated in North Carolina, USA, it will serve as a single point of contact for North America, Latin America and Canada. Our dedicated support team will assist you with all your queries related to bioprocess needs, starting from product to process optimization, to troubleshooting. We offer comprehensive support services, ensuring you have a reliable partner throughout your research journey.

Our Journey

Foundation of OmniBRx​

Founded in 2016 by a team of visionary engineers and bioprocess experts, OmniBRx set out to revolutionize single-use bioreactor technology with scalable, affordable, and innovation – first solutions.:

Product Development​

By 2017, OmniBRx had translated its vision into action—developing and testing early prototypes of the CellBRx® bioreactor system, designed for high-density, adherent cell culture.

Prototyping & Product validation​

In 2018,OmniBRx completed full-scale prototyping and rigorous product validation of the CellBRx® system, ensuring it met industry standards for performance, sterility, and scalability.​

Launch of the first Product​

OmniBRx proudly launched its flagship product, the CellBRx® bioreactor system, in 2019, introducing a scalable, single-use solution purpose-built for high-density adherent cell culture. This marked the beginning of our commercial journey, empowering biomanufacturers with unmatched flexibility and performance.​

Scaling up to 1500m2​

To meet growing demand, OmniBRx expanded its manufacturing footprint to a 1500m² facility in 2020. This scale-up enabled in-house production, faster turnaround, and greater control over quality—paving the way for global supply.​

Development of Seed Bioreactor systems & integration ​

In 2021, OmniBRx expanded its portfolio with the development of seed bioreactor systems, enabling end-to end integration from inoculum to production scale. This innovation streamlined upstream workflows and strengthened our position as a complete bioprocessing solution provider.​

Product Launch: CellBRx IST​

In 2022, OmniBRx unveiled CellBRx® IST (Integrated Seed Train), a breakthrough single-use bioreactor system designed to simplify and accelerate seed train operations. This launch reinforced our commitment to end-to-end bioprocess integration and scalable innovation.​

Investor onboarding: Series-A funding​

In 2023, OmniBRx secured Series-A funding, marking a significant vote of confidence from strategic investors. This milestone accelerated our global expansion, R&D capabilities, and next-gen product development.​

Commercialization of MiniBRx HT systems

In 2024, OmniBRx successfully commercialized the MiniBRx® HT, a high-throughput, single-use bioreactor platform tailored for rapid process development and early-stage screening. Designed for speed, precision, and scalability, MiniBRx® HT empowers researchers with unmatched efficiency in upstream innovation​

Development of StirBRx and PerfBRx Bioreactor systems​

In 2025, OmniBRx advanced its innovation pipeline with the development of StirBRx®—a next-gen stirred-tank bioreactor and PerfBRx®, a perfusion-enabled system built for continuous bioprocessing. These platforms reflect our commitment to flexible, scalable solutions across evolving cell culture needs.​

Achievements and Recognitions

Our Recognitions

Our Collaborations and Partners

OmniBRx collaborates with leading global institutions, biopharma innovators, and research organizations to advance scalable bioprocessing technologies and accelerate the development of next-generation cell and gene therapies.

Our Investors

Certification

Our Team Members

Meet Our Exceptional Team: The driving force behind our success. Discover the passion and Talent that fuels our work, as We commit to delivering excellence and making a meaningful Impact

Ravindra Patel

Chief Executive Officer

Rohit Verma

Chief Automation Officer

Jailesh Patel

Supply & Chain Management

Sapana Patel

Quality Department

Aashvi Shah

Purchase Department

Keyur Shah

New Product Design & Development

Shivani Acharya

Client Communication